• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Anti-Aging
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

The Weekly Roundup: September 4-8


ICYMI, this week we had articles about acne vulgaris management from an expert panel, a look back at summer dermatology conferences, long-term results of roflumilast cream 0.15% for AD, and more.

POLL: What Is The Most Common Skin Care 'Mistake' You Have Observed Among Your Patients?

This Skin Care Awareness Month, Dermatology Times wants to hear your insights. Click here to answer this week's poll.

Top 5 Clinical Pearls for Acne Vulgaris Management

Catch up on acne vulgaris treatment pearls from Dermatology Times’ most recent Frontline Forum series, featuring James Del Rosso, DO; Hilary Baldwin, MD; Neal Bhatia, MD; Christopher Bunick, MD, PhD; and Leon Kircik, MD.

Superficial and Deep Midfacial Injections Offer Significant Results

Researchers found no statistically significant difference between injection techniques.

Chronic Immune-Related Adverse Events Common in Anti-PD-1 Therapy for Melanoma

Endocrine toxic effects were more likely than nonendocrine to become chronic and continue at last follow-up.

POLL: What Topical Treatments Do You Find the Most Efficacious in Acne Vulgaris Management?

Click here to answer this week's acne poll.

ICYMI: Atopic Dermatitis Insight at SPD

Two poster presentations at this year’s Society for Pediatric Dermatology Meeting delve into the psychological impact of the condition and a new option for management.

A Look Back at Summer Conferences and Coverage

Dermatology Times is reflecting on this summer's dermatology conferences with a recap of our top 3 articles from Fall Clinical, Maui Derm, World Congress, SDPA, and SPD.

Pointers With Portela: Jimmy Buffett and Merkel Cell Carcinoma

In this week’s Pointers With Portela, the 208SkinDoc takes an in-depth look at Merkel cell carcinoma after Jimmy Buffett passed away from a 4-year battle with the rare form of skin cancer.

Global Deaths From Melanoma Predicted to Increase 50% by 2040

Melanoma cases were almost 10 times higher in high Human Development Index countries than in low.

Platelet-Rich Plasma May Be Effective as a Therapeutic Option For Vitiligo

PRP is both safe and effective and may be used as a therapeutic option or alternative in conditions like vitiligo or in wound healing.

VIOLIN Study Examines Extent of Burden of Disease in French Vitiligo Patients

The VIOLIN study examined the burden of disease, prevalence, and treatment of vitiligo in patients in France.

Ceramide-Containing Skin Care May Improve Prescription Acne Treatment Adherence

A panel of 9 dermatologists met and created 5 statements regarding the role of ceramide-containing skin care products in reducing skin barrier dysfunction related to acne treatments.

POLL: What is an Ideal Initial Treatment for Low-Risk Basal Cell Carcinoma?

Click here to answer this week's skin cancer poll.

Clinical Specialization Impacts Treatment in Psoriatic Arthritis

Patients treated by rheumatologists were more often treated with tumor necrosis factor inhibitors.

PIILIF Present in Patients With Acne Keloidalis Nuchae

Perifollicular infundibulo-isthmic lymphocytoplasmic infiltrates and fibrosis appeared in all patients, regardless of ethnicity.

Reflecting On 10 Years of Atopic Dermatitis Research

As we approach National Eczema Week and National Eczema Month, take a look at the most influential atopic dermatitis research from the last decade.

Italian Clinicians Share Cost-Effectiveness of Baricitinib Versus Dupilumab

The review found that utilizing dupilumab to treat these patients with AD cost more than using baricitinib, although dupilumab was more effective.

Arcutis Announces Positive Long-Term Results of Roflumilast Cream 0.15% for AD

Roflumilast maintained disease control when patients switched to twice-weekly dosing.

LEAP-010 Study Discontinued for Patients with PD-L1-Expressing HNSCC

A coprimary end point in the phase 3 LEAP-010 study will not be met.

QR678 Neo Effective in Treating Scalp Seborrheic Dermatitis

Significant improvement was shown in erythema and pruritis and patients reported high satisfaction.

Dermoscopy Assessment Showed Efficacy of Botulinum Toxin A in Egyptian Patients With Androgenetic Alopecia

BTA treatment was both safe and effective in male and female patients, indicating its potential as a therapeutic strategy in treating Egyptian patients with AGA.

Botox Cosmetic and IFundWomen Support Women Entrepreneurs

Recipients of the IFundWomen grant kicked off crowdfunding campaigns to grow their businesses.

Oral Macrolides Demonstrate Efficacy in Aseptic Facial Granuloma

The condition may present as a manifestation of pediatric rosacea.

Minoxidil-Spironolactone Therapy Effective in Treating Hair Loss in Women

Topical minoxidil combined with oral spironolactone significantly improved hair density.

Journal Digest: September 8

This week’s collection of the latest dermatologic studies covers the hair regrowth cycle in mice, considering large language models in dermatology, cutaneous leiomyosarcomas subtypes, and the efficacy of tralokinumab in older adults with atopic dermatitis.

Frontier Dermatology Unites 35 Offices in Pacific Northwest

The physician-owned practice combines residency and Mohs fellowship programs with patient care.

Atezolizumab Combo Results in Intracranial Activity in BRAFV600+ Melanoma

Second-line end points of the TRICOTEL trial assessing atezolizumab plus vemurafenib and cobimetinib in melanoma with central nervous system metastases appear consistent with primary efficacy end points.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.